Sign Up to like & get
recommendations!
1
Published in 2022 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics14112468
Abstract: Pharmacogenetics plays a key role in personalized cancer treatment. Currently, the clinically available pharmacogenetic markers for metastatic colorectal cancer (mCRC) are in genes related to drug metabolism, such as DPYD for fluoropyrimidines and UGT1A1 for…
read more here.
Keywords:
pharmacogenetics role;
genetic variants;
role;
review ... See more keywords